Literature DB >> 29326707

Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism.

Gábor Oroszlán1, Ráhel Dani1, András Szilágyi1, Péter Závodszky1, Steffen Thiel2, Péter Gál1, József Dobó1.   

Abstract

Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated SPs (MASP)-1, and MASP-2, which are known to be present as proenzymes in blood. The third SP of the lectin pathway, MASP-3, was recently shown to be the major activator, and the exclusive "resting blood" activator of profactor D, producing factor D, the initiator protease of the alternative pathway. Because only activated MASP-3 is capable of carrying out this cleavage, it was presumed that a significant fraction of MASP-3 must be present in the active form in resting blood. Here, we aimed to detect active MASP-3 in the blood by a more direct technique and to quantitate the active to zymogen ratio. First, MASPs were partially purified (enriched) from human plasma samples by affinity chromatography using immobilized MBL in the presence of inhibitors. Using this MASP pool, only the zymogen form of MASP-1 was detected by Western blot, whereas over 70% MASP-3 was in an activated form in the same samples. Furthermore, the active to zymogen ratio of MASP-3 showed little individual variation. It is enigmatic how MASP-3, which is not able to autoactivate, is present mostly as an active enzyme, whereas MASP-1, which has a potent autoactivation capability, is predominantly proenzymic in resting blood. In an attempt to explain this phenomenon, we modeled the basal level fluid-phase activation of lectin pathway proteases and their subsequent inactivation by C1 inhibitor and antithrombin using available and newly determined kinetic constants. The model can explain extensive MASP-3 activation only if we assume efficient intracomplex activation of MASP-3 by zymogen MASP-1. On the other hand, the model is in good agreement with the fact that MASP-1 and -2 are predominantly proenzymic and some of them is present in the form of inactive serpin-protease complexes. As an alternative hypothesis, MASP-3 activation by proprotein convertases is also discussed.

Entities:  

Keywords:  autoactivation; complement; innate immunity; lectin pathway; proenzyme; reaction kinetics; serine protease

Year:  2017        PMID: 29326707      PMCID: PMC5741598          DOI: 10.3389/fimmu.2017.01821

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  61 in total

1.  MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity.

Authors:  József Dobó; Veronika Harmat; László Beinrohr; Edina Sebestyén; Péter Závodszky; Péter Gál
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

2.  Lectin complement pathway proteins in healthy individuals.

Authors:  A Troldborg; A Hansen; S W K Hansen; J C Jensenius; K Stengaard-Pedersen; S Thiel
Journal:  Clin Exp Immunol       Date:  2017-01-18       Impact factor: 4.330

3.  Structural insights into the initiating complex of the lectin pathway of complement activation.

Authors:  Troels R Kjaer; Le T M Le; Jan Skov Pedersen; Bjoern Sander; Monika M Golas; Jens Christian Jensenius; Gregers R Andersen; Steffen Thiel
Journal:  Structure       Date:  2015-01-08       Impact factor: 5.006

Review 4.  Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins.

Authors:  Steffen Thiel
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

5.  Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.

Authors:  Géza Ambrus; Péter Gál; Mayumi Kojima; Katalin Szilágyi; Júlia Balczer; József Antal; László Gráf; Andreas Laich; Beryl E Moffatt; Wilhelm Schwaeble; Robert B Sim; Péter Závodszky
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 6.  Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation.

Authors:  József Dobó; Verena Schroeder; Lorenz Jenny; László Cervenak; Péter Závodszky; Péter Gál
Journal:  Mol Immunol       Date:  2014-06-14       Impact factor: 4.407

7.  Purification, crystallization and preliminary X-ray analysis of human mannose-binding lectin-associated serine protease-1 (MASP-1) catalytic region.

Authors:  József Dobó; Veronika Harmat; Edina Sebestyén; László Beinrohr; Péter Závodszky; Péter Gál
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-08-09

Review 8.  The tick-over theory revisited: is C3 a contact-activated protein?

Authors:  Bo Nilsson; Kristina Nilsson Ekdahl
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

9.  MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked.

Authors:  József Dobó; Dávid Szakács; Gábor Oroszlán; Elod Kortvely; Bence Kiss; Eszter Boros; Róbert Szász; Péter Závodszky; Péter Gál; Gábor Pál
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

10.  C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.

Authors:  M M Ruseva; M Takahashi; T Fujita; M C Pickering
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

View more
  8 in total

Review 1.  Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.

Authors:  József Dobó; Andrea Kocsis; Péter Gál
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

2.  Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Authors:  Carles Vilariño-Güell; Alexander Zimprich; Filippo Martinelli-Boneschi; Bruno Herculano; Zhe Wang; Fuencisla Matesanz; Elena Urcelay; Koen Vandenbroeck; Laura Leyva; Denis Gris; Charbel Massaad; Jacqueline A Quandt; Anthony L Traboulsee; Mary Encarnacion; Cecily Q Bernales; Jordan Follett; Irene M Yee; Maria G Criscuoli; Angela Deutschländer; Eva M Reinthaler; Tobias Zrzavy; Elisabetta Mascia; Andrea Zauli; Federica Esposito; Antonio Alcina; Guillermo Izquierdo; Laura Espino-Paisán; Jorge Mena; Alfredo Antigüedad; Patricia Urbaneja-Romero; Jesús Ortega-Pinazo; Weihong Song; A Dessa Sadovnick
Journal:  PLoS Genet       Date:  2019-06-06       Impact factor: 5.917

3.  ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism.

Authors:  Rasmus Pihl; Rasmus K Jensen; Emil C Poulsen; Lisbeth Jensen; Annette G Hansen; Ida B Thøgersen; József Dobó; Péter Gál; Gregers R Andersen; Jan J Enghild; Steffen Thiel
Journal:  Sci Adv       Date:  2021-01-08       Impact factor: 14.136

Review 4.  The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?

Authors:  Felix Poppelaars; Bernardo Faria; Wilhelm Schwaeble; Mohamed R Daha
Journal:  J Clin Med       Date:  2021-10-14       Impact factor: 4.241

Review 5.  Proprotein Convertases and the Complement System.

Authors:  József Dobó; Andrea Kocsis; Ráhel Dani; Péter Gál
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

6.  The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation.

Authors:  Kohei Kusakari; Takeshi Machida; Yumi Ishida; Tomoko Omori; Toshiyuki Suzuki; Masayuki Sekimata; Ikuo Wada; Teizo Fujita; Hideharu Sekine
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

7.  Mannan-binding lectin serine protease-2 (MASP-2) in human kidney and its relevance for proteolytic activation of the epithelial sodium channel.

Authors:  Rikke Zachar; Steffen Thiel; Søren Hansen; Maiken Lumby Henriksen; Mikkel-Ole Skjoedt; Karsten Skjodt; Zohra Hamzaei; Kirsten Madsen; Lars Lund; Edith Hummler; Per Svenningsen; Boye Lagerbon Jensen
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

Review 8.  Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Authors:  V Michael Holers; Nirmal K Banda
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.